Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD.

Arora S, Baig F, Lo C, Barber TR, Lawton MA, Zhan A, Rolinski M, Ruffmann C, Klein JC, Rumbold J, Louvel A, Zaiwalla Z, Lennox G, Quinnell T, Dennis G, Wade-Martins R, Ben-Shlomo Y, Little MA, Hu MT.

Neurology. 2018 Oct 16;91(16):e1528-e1538. doi: 10.1212/WNL.0000000000006366. Epub 2018 Sep 19.

2.

Long-term compliance, safety, and tolerability of sodium oxybate treatment in patients with narcolepsy type 1: a postauthorization, noninterventional surveillance study.

Mayer G, Plazzi G, Iranzo Á, Ortega-Albás J, Quinnell T, Pesch H, Serralheiro P, Schlit AF, Wuiame D, Bentz JWG.

Sleep. 2018 Sep 1;41(9). doi: 10.1093/sleep/zsy128.

PMID:
29986085
3.

An update on mandibular advancement devices for the treatment of obstructive sleep apnoea hypopnoea syndrome.

Basyuni S, Barabas M, Quinnell T.

J Thorac Dis. 2018 Jan;10(Suppl 1):S48-S56. doi: 10.21037/jtd.2017.12.18. Review.

4.

Apathy in rapid eye movement sleep behaviour disorder is common and under-recognized.

Barber TR, Muhammed K, Drew D, Lawton M, Crabbe M, Rolinski M, Quinnell T, Zaiwalla Z, Ben-Shlomo Y, Husain M, Hu MTM.

Eur J Neurol. 2018 Mar;25(3):469-e32. doi: 10.1111/ene.13515. Epub 2017 Dec 14.

5.

Autocannibalism induced by obstructive sleep apnea.

Basyuni S, Quinnell T.

Sleep Med. 2017 Sep;37:72-73. doi: 10.1016/j.sleep.2017.01.017. Epub 2017 Mar 6. No abstract available.

PMID:
28899543
6.

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.

Barber TR, Lawton M, Rolinski M, Evetts S, Baig F, Ruffmann C, Gornall A, Klein JC, Lo C, Dennis G, Bandmann O, Quinnell T, Zaiwalla Z, Ben-Shlomo Y, Hu MTM.

Sleep. 2017 Aug 1;40(8). doi: 10.1093/sleep/zsx071.

7.

Hospital outcomes and long-term survival after referral to a specialized weaning unit.

Davies MG, Quinnell TG, Oscroft NS, Clutterbuck SP, Shneerson JM, Smith IE.

Br J Anaesth. 2017 Apr 1;118(4):563-569. doi: 10.1093/bja/aex031.

8.
9.

Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.

Rolinski M, Griffanti L, Piccini P, Roussakis AA, Szewczyk-Krolikowski K, Menke RA, Quinnell T, Zaiwalla Z, Klein JC, Mackay CE, Hu MT.

Brain. 2016 Aug;139(Pt 8):2224-34. doi: 10.1093/brain/aww124. Epub 2016 Jun 12.

10.

Visual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson's disease.

Rolinski M, Zokaei N, Baig F, Giehl K, Quinnell T, Zaiwalla Z, Mackay CE, Husain M, Hu MT.

Brain. 2016 Jan;139(Pt 1):47-53. doi: 10.1093/brain/awv334. Epub 2015 Nov 18.

11.

Response to comments on "Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea".

Sharples LD, Quinnell TG; TOMADO investigators.

Sleep Med Rev. 2016 Jun;27:41-2. doi: 10.1016/j.smrv.2015.08.001. Epub 2015 Aug 13. No abstract available.

PMID:
26447848
12.

Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea.

Sharples LD, Clutterbuck-James AL, Glover MJ, Bennett MS, Chadwick R, Pittman MA, Quinnell TG.

Sleep Med Rev. 2016 Jun;27:108-24. doi: 10.1016/j.smrv.2015.05.003. Epub 2015 May 30. Review.

13.

Unmet needs of patients with narcolepsy: perspectives on emerging treatment options.

Wozniak DR, Quinnell TG.

Nat Sci Sleep. 2015 May 22;7:51-61. doi: 10.2147/NSS.S56077. eCollection 2015. Review.

14.

Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.

Sharples L, Glover M, Clutterbuck-James A, Bennett M, Jordan J, Chadwick R, Pittman M, East C, Cameron M, Davies M, Oscroft N, Smith I, Morrell M, Fox-Rushby J, Quinnell T.

Health Technol Assess. 2014 Oct;18(67):1-296. doi: 10.3310/hta18670.

15.

Alternatives to continuous positive airway pressure 2: mandibular advancement devices compared.

Quinnell TG, Clutterbuck-James AL.

Curr Opin Pulm Med. 2014 Nov;20(6):595-600. doi: 10.1097/MCP.0000000000000096. Review.

PMID:
25221854
16.

Volume assured versus pressure preset non-invasive ventilation for compensated ventilatory failure in COPD.

Oscroft NS, Chadwick R, Davies MG, Quinnell TG, Smith IE.

Respir Med. 2014 Oct;108(10):1508-15. doi: 10.1016/j.rmed.2014.07.010. Epub 2014 Jul 23.

17.

A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea (TOMADO).

Quinnell TG, Bennett M, Jordan J, Clutterbuck-James AL, Davies MG, Smith IE, Oscroft N, Pittman MA, Cameron M, Chadwick R, Morrell MJ, Glover MJ, Fox-Rushby JA, Sharples LD.

Thorax. 2014 Oct;69(10):938-45. doi: 10.1136/thoraxjnl-2014-205464. Epub 2014 Jul 17.

PMID:
25035126
18.

Obstructive sleep apnoea: relevance to non-sleep clinicians.

Smith IE, Quinnell TG.

Clin Med (Lond). 2011 Jun;11(3):286-9. Review. No abstract available.

19.

Narcolepsy, idiopathic hypersomnolence and related conditions.

Quinnell TG, Smith IE.

Clin Med (Lond). 2011 Jun;11(3):282-6. No abstract available.

20.

A randomised crossover trial comparing volume assured and pressure preset noninvasive ventilation in stable hypercapnic COPD.

Oscroft NS, Ali M, Gulati A, Davies MG, Quinnell TG, Shneerson JM, Smith IE.

COPD. 2010 Dec;7(6):398-403. doi: 10.3109/15412555.2010.528084.

PMID:
21166627
21.

Long-term non-invasive ventilation to manage persistent ventilatory failure after COPD exacerbation.

Oscroft NS, Quinnell TG, Shneerson JM, Smith IE.

Respirology. 2010 Jul;15(5):818-22. doi: 10.1111/j.1440-1843.2010.01787.x. Epub 2010 Jun 9.

PMID:
20546195
22.

The effects of withdrawing long-term nocturnal non-invasive ventilation in COPD patients.

Oscroft NS, Quinnell TG, Shneerson JM, Smith IE.

COPD. 2010 Apr;7(2):111-6. doi: 10.3109/15412551003631725.

PMID:
20397811
23.

Screening the human prepro-orexin gene in a single-centre narcolepsy cohort.

Quinnell TG, Farooqi IS, Smith IE, Shneerson JM.

Sleep Med. 2007 Aug;8(5):498-502. Epub 2007 Jun 18.

PMID:
17576097
24.

An uncommon cause of heart failure.

Church AC, Quinnell T.

QJM. 2007 Feb;100(2):139. Epub 2006 Dec 12. No abstract available.

PMID:
17164323
25.
26.

Ventilatory responses to hypoxia and hypercapnia in stable methadone maintenance treatment patients.

Teichtahl H, Wang D, Cunnington D, Quinnell T, Tran H, Kronborg I, Drummer OH.

Chest. 2005 Sep;128(3):1339-47.

PMID:
16162727
27.

Pharmacotherapies for obstructive sleep apnoea: where are we now?

Smith IE, Quinnell TG.

Drugs. 2004;64(13):1385-99. Review.

PMID:
15212557
28.

Obstructive sleep apnoea in the elderly: recognition and management considerations.

Quinnell TG, Smith IE.

Drugs Aging. 2004;21(5):307-22. Review.

PMID:
15040758
29.

Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.

Rustin GJ, Quinnell TG, Johnson J, Clarke H, Nelstrop AE, Bollag W.

Br J Cancer. 1996 Nov;74(9):1479-81.

Supplemental Content

Loading ...
Support Center